Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Ligand and Parke-Davis establish research collaboration

Sep. 6, 1999

Licensing opportunity from NIH: drug delivery system for water-insoluble drugs

Sep. 6, 1999

Orally bioavailable, ETB receptor-selective antagonists designed by Abbott

Sep. 3, 1999

Millennium extends CNS collaboration with Wyeth-Ayerst

Sep. 2, 1999

Repligen receives SBIR grants to support discovery of novel active compounds

Aug. 27, 1999

Pharmacopeia to provide lead discovery services to Roche Bioscience

Aug. 27, 1999

Sangamo and Schering AG enter research agreement for Universal GeneTools technology

Aug. 26, 1999

Study commences of pulmonary delivery of migraine therapy

Aug. 23, 1999

Stem Cell Sciences and Rhone-Poulenc Rorer enter agreement

Aug. 23, 1999

ImmGenics' SLAM technology presented at conference

Aug. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...